Emerging healthtech investor Accelmed closes Fund II at $400m hard cap
In a competitive US healthcare deal market, Accelmed's strategy puts it “below the radar of the big guns,” managing partner Uri Geiger told Buyouts.
16 March 2021•3 mins read
In a competitive US healthcare deal market, Accelmed's strategy puts it “below the radar of the big guns,” managing partner Uri Geiger told Buyouts.
Meet the family: PPC is sticking to what it knows best
23 October 2026 · 3 mins read
KKR’s Alisa Wood: PE isn’t worth it if you can’t access top GPs
21 October 2026 · 3 mins read
New Hunter Point Capital COO and president maps out strategy
23 September 2026 · 5 mins read
Advent International targets $3bn for debut mid-market fund
22 September 2026 · 2 mins read
Off-duty: Abry’s CJ Brucato on football, 'Stairway to Heaven' and Sunday Italian gravy
21 September 2026 · 7 mins read
Why it pays to play ball during LP-leds
18 September 2026 · 2 mins read
Lower-mid market Siguler Guff leverages exits to its biggest fundraise
18 September 2026 · 3 mins read
